	Fulvestrant versus capecitabine as maintenance therapy in hormone receptor-positive, HER2-negative metastatic breast cancer after first-line chemotherapy (FAMILY): a multicenter, open-label, randomized, phase 3 trial. Signal Transduct Target Ther Wu W, Yang Y, Chen H, Lu Y, Zeng Y, Zhao J, Du C, Lin Y, Peng P, Huang M, Zhang Y, Ouyang Q, Ding L, Cheng Z, Wen Y, Wu Z, Ye J, Ling L, Wang K, Lu Y, Zou G, Zhong J, Wang H, Lin D, Zeng D, Yao C, Chen Q, Zou L, Wang S, Yu Y, Yuan Z, Wang Y, Yao H. PMID: 42168151 [PubMed - indexed for MEDLINE]
	RÃ©daction dâ€™un modÃ¨le de directives anticipÃ©es appropriÃ© pour les femmes atteintes dâ€™un cancer du seinÂ : mÃ©thode Delphi. Sante Publique Frèche B, Martinet A, Carneiro Y, Besnier M, Poupin É. PMID: 42168093 [PubMed - indexed for MEDLINE]
	Immune Checkpoint Inhibitors in Elderly Patients With Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis of Subgroup Evidence. Clin Breast Cancer Carlos MIR, Mello JS, Marçalo de Tolosa AL, Cardoso MR, Brando S BG, Carlos ACR, de Moraes FCA. PMID: 42168077 [PubMed - as supplied by publisher]
	"Breast cancer with a good prognosis in elderly patients: Is sentinel lymph node biopsy still justified?". Cir Esp (Engl Ed) Domínguez CL, Novoa AG, Nebril BA, Rojo SR, Caamaño AG. PMID: 42167728 [PubMed - as supplied by publisher]
	Datopotamab deruxtecan (Dato-DXd) in combination with durvalumab as first-line treatment for unresectable locally advanced or metastatic triple-negative breast cancer: results from arms 7 and 8 of the phase Ib/II BEGONIA study. Ann Oncol Schmid P, Wang HC, Lynce F, Asselah J, Jung KH, Ma CX, Park YH, Chen SC, Wysocki PJ, Baird RD, Nowecki Z, Fernandes R, O'Shaughnessy J, Lord S, Hou MF, Tseng LM, Prady C, Rao-Melacini P, Stewart R, Warzyszy, Vukovi, Im SA. PMID: 42167437 [PubMed - as supplied by publisher]
	Baseline FDG PET/CT-Defined Axillary Burden Predicts Axillary Pathologic Complete Response After Neoadjuvant Therapy in Breast Cancer. Nuklearmedizin Tato, Ökten , Ibisoglu E, Söylemez Akkurt T, Yerdelen Tato, Uslu H, Baysal H. PMID: 42167287 [PubMed - indexed for MEDLINE]
	Comparative study of time- and frequency-difference electrical impedance tomography for breast cancer detection. Biomed Phys Eng Express Gutiérrez López M, Gutierrez Gnecchi JA, Yang W, Reyes Archundia E, Rodriguez Herrejon JA, Robledo Ayala AI, Garcia L. PMID: 42167277 [PubMed - as supplied by publisher]
	Defining surgical fitness in advanced ovarian cancer: a critical review of predictors, algorithms, and pre-habilitation. Int J Gynecol Cancer Ribero L, Fumagalli D, De Vitis LA, Caruso G, Schivardi G, Aletti G, Colombo N, Kumar A, Ramirez PT, Multinu F. PMID: 42167107 [PubMed - as supplied by publisher]
	A DNA Methylation-based algorithm Improves Lung Cancer risk prediction in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Lung Cancer Dawes K, Mills JA, Hoffman RM, Froehlich EM, deBlois K, Sieren JC, Williams C, Merkle S, Long JD, Beach SR, Philibert RA. PMID: 42167026 [PubMed - as supplied by publisher]
	Lower breast cancer risk among women with two Hakka parents in Taiwan: A nationwide population-based study. Cancer Epidemiol Wu CC, Nfor ON, Hsu SY, Wang KS, Liaw YP. PMID: 42166871 [PubMed - as supplied by publisher]
	Evolution of ER-cut-off definition in clinical trials for triple negative breast cancer: trends and patterns over 15 years. Breast Bonomi G, Napetti D, Griguolo G, Zanghì F, Girardi F, Lando S, Napolitano P, Landa G, La Commare M, Massa D, Guarneri V, Dieci MV. PMID: 42166831 [PubMed - as supplied by publisher]
	Enhancing the OncoSim-Breast model using Canadian breast density information. Health Rep Alagoz O, Garner R, Nadeau C, Coldman A, Yong JHE, Yaffe MJ, Mainprize JG, Simeonov D. PMID: 42166779 [PubMed - indexed for MEDLINE]
	Estradiol-to-oocyte ratio as a prognostic biomarker of assisted reproductive outcomes in women with polycystic ovary syndrome: The impact of LH activity. Womens Health (Lond) Salovic B, Soldatovic I, Stojsavljevic A, Dikic SD, Nikolic A, Gerginic V, Zafirovic S, Isenovic ER, Perovic M. PMID: 42166652 [PubMed - indexed for MEDLINE]
	Cardio-oncology disparities in breast cancer: mapping the social gradient of dual disease burden. Curr Med Res Opin Obeidat O, Obeidat A, Alqudah Q, El Khatib S, Daise M, Sood R, Tarawneh M, Al-Ani H, Alhuneafat L, Ismail MF, Obeidat A, Obeidat M, Tong A. PMID: 42166526 [PubMed - as supplied by publisher]
	Recent advancements in microtubule targeting agents for breast cancer: design strategies and pharmacological insights. Mol Divers Kaur P, Sharma R. PMID: 42166105 [PubMed - as supplied by publisher]
	Diagnostic accuracy of contrast-enhanced mammography in evaluating breast cancer response to neoadjuvant therapy: a systematic review and meta-analysis. Radiol Med Galati F, Katouli FS, Maroncelli R, Barcaroli G, Azizi N, Spagnoli A, Fabrizi E, Pediconi F. PMID: 42165975 [PubMed - as supplied by publisher]
	The role of targeted exosomes in improving drug delivery in breast cancer: challenges and prospects. Mol Biol Rep Moghadam MZ, Shafieesabet M, Jamshidi N, Jamshidi N. PMID: 42165907 [PubMed - indexed for MEDLINE]
	Cardiac Radiation Dose and Subclinical Coronary Artery Disease Progression after Breast Cancer Radiotherapy: 2-year Cardiac CT Results from the EARLY-HEART Study. Radiol Cardiothorac Imaging Mousseaux E, Craiem D, Vliegenthart R, Jacob S, Eraso A, Constantino Rosa Santos S, Borm K, Langendijk JA, Locquet M, Ventura M, Fiúza M, Combs SE, Spoor DS, Crijns APG, MEDIRAD EARLY-HEART investigators. PMID: 42165741 [PubMed - indexed for MEDLINE]
	POLE mutations in endometrial carcinoma from a tertiary cancer care centre in eastern India. Indian J Med Res Faizal F, Vinarkar S, Midha D, Banerjee S, Sabnam S, Bhattacharjee C, Parihar M, Bhaumik J, Mishra D. PMID: 42165733 [PubMed - indexed for MEDLINE]
	Uterine intra-leiomyoma metastasis originating from primary breast cancer: A rare entity. Int J Gynaecol Obstet Bartholomew V, Lopez N, Schammel CMG, Devane AM, Schammel DP. PMID: 42165695 [PubMed - as supplied by publisher]

Articles 1 - 20 / 329002

Page 1 of 16451



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy